Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Lab Accredited By College of American Pathologists

NEW YORK (GenomeWeb News) – Transgenomic announced today that the College of American Pathologists’ Commission on Laboratory Accreditation has awarded its laboratory an accreditation following a recent on-site inspection, making Transgenomic one of more than 6,000 CAP-accredited American labs.
CAP started its Laboratory Accreditation Program nearly half a century ago. It is reportedly regarded by the federal government as being as or more stringent than the government inspection program. The program involves evaluation of laboratory records, quality control procedures, staff qualifications, management, and laboratory equipment, facilities, and safety records.
Transgenomic CEO Craig Tuttle called the accreditation a validation of the company’s laboratory services. “We plan to immediately pursue the benefits of the accreditation in our pursuit of projects and revenue growth,” he said in a statement. “We are confident that CAP accreditation will put Transgenomic on the map as a laboratory with the highest standard in molecular diagnostics.”
Transgenomic offers products and services for evaluating genetic variation and mutation analysis.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.